Ligand · TT2
TT2 · (1R,3R,7E,17beta)-17-{(1S,2E,5R)-5-hydroxy-1-methyl-5-[(3S,5S,7S)-tricyclo[3.3.1.1~3,7~]dec-1-yl]pent-2-en-1-yl}-2-methylidene-9,10-secoestra-5,7-diene-1,3-diol
TT2, (1R,3R,7E,17beta)-17-{(1S,2E,5R)-5-hydroxy-1-methyl-5-[(3S,5S,7S)-tricyclo[3.3.1.1~3,7~]dec-1-yl]pent-2-en-1-yl}-2-methylidene-9,10-secoestra-5,7-diene-1,3-diol (C35 H52 O3, 520.8 g/mol), in the MolNFT structures on GenesisL1: bound…
- Component
- TT2
- Formula
- C35 H52 O3
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
TT2 in 2 structures; the first of them:
- 2ZMI · Crystal Structure of Rat Vitamin D Receptor Bound to Adamantyl Vitamin D Analogs… · TT2 A1 · binds TYR143, TYR147, PHE150, LEU223, LEU226, ALA227, LEU229, VAL230 and 20 more
- 2ZMI · Crystal structure of rat vitamin D receptor bound to adamantyl vitamin D analogs… · TT2 A1 · binds TYR143, TYR147, PHE150, LEU223, LEU226, ALA227, LEU229, VAL230 and 20 more
Residues it binds most
LEU 2, TYR 2, SER 2, VAL 2, ALA 2, HIS 2, ILE 2, ARG 2, CYS 2, MET 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.